Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury

Michael A. Holland, Arlene A. Tan, Douglas C. Smith, Michael R. Hoane

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP+ astrocytes and FJ+ neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP+ astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP+ astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.

Original languageEnglish (US)
Pages (from-to)140-152
Number of pages13
JournalJournal of Neurotrauma
Volume25
Issue number2
DOIs
StatePublished - Feb 1 2008
Externally publishedYes

Fingerprint

Percussion
Niacinamide
Glial Fibrillary Acidic Protein
Wounds and Injuries
Astrocytes
Recovery of Function
Neuroprotection
Thalamus
Brain Injuries
Rodentia
Hippocampus
Neurons
Brain

Keywords

  • Fluoro-jade
  • GFAP
  • Neuroprotection
  • Nicotinamide
  • Therapy
  • Traumatic brain injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. / Holland, Michael A.; Tan, Arlene A.; Smith, Douglas C.; Hoane, Michael R.

In: Journal of Neurotrauma, Vol. 25, No. 2, 01.02.2008, p. 140-152.

Research output: Contribution to journalArticle

Holland, Michael A. ; Tan, Arlene A. ; Smith, Douglas C. ; Hoane, Michael R. / Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. In: Journal of Neurotrauma. 2008 ; Vol. 25, No. 2. pp. 140-152.
@article{debd5a27f313480e9e02a091efab5ab0,
title = "Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury",
abstract = "Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP+ astrocytes and FJ+ neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP+ astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP+ astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.",
keywords = "Fluoro-jade, GFAP, Neuroprotection, Nicotinamide, Therapy, Traumatic brain injury",
author = "Holland, {Michael A.} and Tan, {Arlene A.} and Smith, {Douglas C.} and Hoane, {Michael R.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1089/neu.2007.0312",
language = "English (US)",
volume = "25",
pages = "140--152",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury

AU - Holland, Michael A.

AU - Tan, Arlene A.

AU - Smith, Douglas C.

AU - Hoane, Michael R.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP+ astrocytes and FJ+ neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP+ astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP+ astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.

AB - Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP+ astrocytes and FJ+ neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP+ astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP+ astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.

KW - Fluoro-jade

KW - GFAP

KW - Neuroprotection

KW - Nicotinamide

KW - Therapy

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=39149085009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149085009&partnerID=8YFLogxK

U2 - 10.1089/neu.2007.0312

DO - 10.1089/neu.2007.0312

M3 - Article

VL - 25

SP - 140

EP - 152

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 2

ER -